409 related articles for article (PubMed ID: 22022233)
1. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.
de Kraker ME; Davey PG; Grundmann H;
PLoS Med; 2011 Oct; 8(10):e1001104. PubMed ID: 22022233
[TBL] [Abstract][Full Text] [Related]
2. [Excess mortality and prolongation of stay due to bloodstream infections caused by multiresistant pathogens in Germany].
Gastmeier P; Schwab F; Meyer E; Geffers C
Dtsch Med Wochenschr; 2012 Aug; 137(34-35):1689-92. PubMed ID: 22893048
[TBL] [Abstract][Full Text] [Related]
3. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.
Stewardson AJ; Allignol A; Beyersmann J; Graves N; Schumacher M; Meyer R; Tacconelli E; De Angelis G; Farina C; Pezzoli F; Bertrand X; Gbaguidi-Haore H; Edgeworth J; Tosas O; Martinez JA; Ayala-Blanco MP; Pan A; Zoncada A; Marwick CA; Nathwani D; Seifert H; Hos N; Hagel S; Pletz M; Harbarth S;
Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562950
[TBL] [Abstract][Full Text] [Related]
4. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
Hassoun-Kheir N; Guedes M; Ngo Nsoga MT; Argante L; Arieti F; Gladstone BP; Kingston R; Naylor NR; Pezzani MD; Pouwels KB; Robotham JV; Rodríguez-Baño J; Tacconelli E; Vella V; Harbarth S; de Kraker MEA;
Clin Microbiol Infect; 2024 Mar; 30 Suppl 1():S14-S25. PubMed ID: 37802750
[TBL] [Abstract][Full Text] [Related]
5. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H
J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563
[TBL] [Abstract][Full Text] [Related]
6. Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: Retrospective database study of Japanese hospitals.
Uematsu H; Yamashita K; Kunisawa S; Fushimi K; Imanaka Y
PLoS One; 2017; 12(6):e0179767. PubMed ID: 28654675
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections.
de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch AJ; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Kelmere AM; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H;
Antimicrob Agents Chemother; 2011 Apr; 55(4):1598-605. PubMed ID: 21220533
[TBL] [Abstract][Full Text] [Related]
8. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
Tsuzuki S; Matsunaga N; Yahara K; Gu Y; Hayakawa K; Hirabayashi A; Kajihara T; Sugai M; Shibayama K; Ohmagari N
J Infect Chemother; 2020 Apr; 26(4):367-371. PubMed ID: 31801696
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
10. Attributable Length of Stay, Mortality Risk, and Costs of Bacterial Health Care-Associated Infections in Australia: A Retrospective Case-cohort Study.
Lee XJ; Stewardson AJ; Worth LJ; Graves N; Wozniak TM
Clin Infect Dis; 2021 May; 72(10):e506-e514. PubMed ID: 32822465
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of methicillin-resistant Staphylococcus aureus bacteremia based on propensity scores.
Park SY; Son JS; Oh IH; Choi JM; Lee MS
Infection; 2011 Apr; 39(2):141-7. PubMed ID: 21424856
[TBL] [Abstract][Full Text] [Related]
12. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
13. Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.
Tsuzuki S; Yu J; Matsunaga N; Ohmagari N
Public Health; 2021 Sep; 198():292-296. PubMed ID: 34507134
[TBL] [Abstract][Full Text] [Related]
14. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
Kim T; Oh PI; Simor AE
Infect Control Hosp Epidemiol; 2001 Feb; 22(2):99-104. PubMed ID: 11232886
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.
Lodise TP; McKinnon PS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):113-22. PubMed ID: 15964499
[TBL] [Abstract][Full Text] [Related]
16. Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study.
MacKinnon MC; McEwen SA; Pearl DL; Lyytikäinen O; Jacobsson G; Collignon P; Gregson DB; Valiquette L; Laupland KB
BMC Infect Dis; 2021 Jun; 21(1):606. PubMed ID: 34172003
[TBL] [Abstract][Full Text] [Related]
17. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.
Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S
BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305
[TBL] [Abstract][Full Text] [Related]
18. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.
Köck R; Becker K; Cookson B; van Gemert-Pijnen JE; Harbarth S; Kluytmans J; Mielke M; Peters G; Skov RL; Struelens MJ; Tacconelli E; Navarro Torné A; Witte W; Friedrich AW
Euro Surveill; 2010 Oct; 15(41):19688. PubMed ID: 20961515
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?
Abramson MA; Sexton DJ
Infect Control Hosp Epidemiol; 1999 Jun; 20(6):408-11. PubMed ID: 10395142
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
